login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
MUSTANG BIO INC (MBIO) Stock News
USA
- NASDAQ:MBIO -
US62818Q3020
-
Common Stock
1.58
USD
+0.01 (+0.64%)
Last: 9/12/2025, 8:00:01 PM
1.6146
USD
+0.03 (+2.19%)
After Hours:
9/12/2025, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
MBIO Latest News, Press Relases and Analysis
All
Press Releases
2 months ago - By: Benzinga
- Mentions:
JAGX
WINT
PRPO
DARE
...
12 Health Care Stocks Moving In Monday's Pre-Market Session
2 months ago - By: Benzinga
- Mentions:
WINT
VRNA
KZIA
RLYB
...
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
2 months ago - By: FN Media Group LLC
- Mentions:
ONCY
ONC.CA
VSTM
CRDF
...
Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies
2 months ago - By: Stocktwits
Mustang Bio Ignites Bullish Retail Buzz As FDA Grants Orphan Status To Brain Cancer Drug
2 months ago - By: Mustang Bio, Inc.
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma
6 months ago - By: Mustang Bio, Inc.
Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement
Please enable JavaScript to continue using this application.